Found: 117
Select item for more details and to access through your institution.
Optimal infused CD34<sup>+</sup> cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01165-w
- By:
- Publication type:
- Article
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01062-2
- By:
- Publication type:
- Article
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01062-2
- By:
- Publication type:
- Article
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00973-w
- By:
- Publication type:
- Article
Infections caused by Mycobacterium tuberculosis in recipients of hematopoietic stem cell transplantation.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00231
- By:
- Publication type:
- Article
Current Approaches to Philadelphia Chromosome–Positive B-Cell Lineage Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitor and Stem Cell Transplant.
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 8, p. 1, doi. 10.1007/s11912-021-01086-y
- By:
- Publication type:
- Article
Humoral Immunity and Antibody Responses against Diphtheria, Tetanus, and Pneumococcus after Immune Effector Cell Therapies: A Prospective Study.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1070, doi. 10.3390/vaccines12091070
- By:
- Publication type:
- Article
Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future.
- Published in:
- Stem Cells Translational Medicine, 2023, v. 12, n. 2, p. 55, doi. 10.1093/stcltm/szac086
- By:
- Publication type:
- Article
Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1944, doi. 10.1111/bjh.19384
- By:
- Publication type:
- Article
Real‐world analysis of safety and efficacy of CAR T‐cell therapy in lymphoma patients with decreased kidney function.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. e11, doi. 10.1111/bjh.19152
- By:
- Publication type:
- Article
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up‐front autologous stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 4, p. 866, doi. 10.1111/bjh.18944
- By:
- Publication type:
- Article
Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 4, p. e37, doi. 10.1111/bjh.18753
- By:
- Publication type:
- Article
Development and validation of a patient‐reported outcome measure to assess symptom burden after chimeric antigen receptor T‐cell therapy.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 4, p. 738, doi. 10.1111/bjh.18677
- By:
- Publication type:
- Article
A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B‐cell acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 442, doi. 10.1111/bjh.14806
- By:
- Publication type:
- Article
A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 4, p. 561, doi. 10.1111/bjh.14731
- By:
- Publication type:
- Article
Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 4, p. 567, doi. 10.1111/bjh.14596
- By:
- Publication type:
- Article
Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 3, p. 392, doi. 10.1111/bjh.13834
- By:
- Publication type:
- Article
The impact of pre-transplant valganciclovir on early cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2014, v. 20, n. 4, p. 257, doi. 10.1177/1078155213501360
- By:
- Publication type:
- Article
Characteristics and outcomes of patients with relapsed Philadelphia chromosome‐positive acute lymphoblastic leukemia after failure of a frontline ponatinib‐containing therapy.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1423, doi. 10.1002/ajh.27329
- By:
- Publication type:
- Article
Safety and long‐term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single‐center phase 1,2 trial.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 836, doi. 10.1002/ajh.27254
- By:
- Publication type:
- Article
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 562, doi. 10.1002/ajh.27233
- By:
- Publication type:
- Article
Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 1, p. 38, doi. 10.1002/ajh.27126
- By:
- Publication type:
- Article
Single‐agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1571, doi. 10.1002/ajh.27029
- By:
- Publication type:
- Article
Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT‐PCR for BCR::ABL1.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1196, doi. 10.1002/ajh.26949
- By:
- Publication type:
- Article
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B‐cell acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 6, p. E142, doi. 10.1002/ajh.26907
- By:
- Publication type:
- Article
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. 712, doi. 10.1002/ajh.26870
- By:
- Publication type:
- Article
Frontline combination of ponatinib and hyper‐CVAD in Philadelphia chromosome‐positive acute lymphoblastic leukemia: 80‐months follow‐up results.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 493, doi. 10.1002/ajh.26816
- By:
- Publication type:
- Article
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E35, doi. 10.1002/ajh.26789
- By:
- Publication type:
- Article
Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. E201, doi. 10.1002/ajh.26526
- By:
- Publication type:
- Article
External validation of the HIGH‐2‐LOW model: A predictive score for venous thromboembolism after allogeneic transplant.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 740, doi. 10.1002/ajh.26521
- By:
- Publication type:
- Article
Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity‐score matched analysis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. E455, doi. 10.1002/ajh.26360
- By:
- Publication type:
- Article
Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. 1137, doi. 10.1002/ajh.26268
- By:
- Publication type:
- Article
Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 1000, doi. 10.1002/ajh.26238
- By:
- Publication type:
- Article
An effective chemotherapy‐free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome‐positive acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. E229, doi. 10.1002/ajh.26175
- By:
- Publication type:
- Article
Manufacture of Clinical-Grade CD19-Specific T Cells Stably Expressing Chimeric Antigen Receptor Using <i>Sleeping Beauty</i> System and Artificial Antigen Presenting Cells
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064138
- By:
- Publication type:
- Article
Outcomes of autologous stem cell transplantation in Waldenström's macroglobulinemia.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Chimeric antigen receptor T‐cell therapy toxicities.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 6, p. 2414, doi. 10.1111/bcp.14403
- By:
- Publication type:
- Article
DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 9, p. 745, doi. 10.1001/jama.2023.1363
- By:
- Publication type:
- Article
Nonmyeloablative Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia in the Imatinib Era.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S261, doi. 10.3816/CLM.2009.s.021
- By:
- Publication type:
- Article
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11712-6
- By:
- Publication type:
- Article
A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19.
- Published in:
- Immunological Reviews, 2014, v. 257, n. 1, p. 181, doi. 10.1111/imr.12137
- By:
- Publication type:
- Article
CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.800110
- By:
- Publication type:
- Article
A randomized study comparing chemotherapy followed by G-CS F alone or in combination with GM-CS F for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomas.
- Published in:
- Journal of Blood Medicine, 2010, v. 1, p. 49, doi. 10.2147/jbm.s9846
- By:
- Publication type:
- Article
New and emerging therapies for acute and chronic graft versus host disease.
- Published in:
- Therapeutic Advances in Hematology, 2018, v. 9, n. 1, p. 21, doi. 10.1177/2040620717741860
- By:
- Publication type:
- Article
Progress in novel cellular therapy options for chronic lymphocytic leukemia: the M D Anderson perspective.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The Development of a Myeloablative, Reduced-Toxicity, Conditioning Regimen for Cord Blood Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2014, v. 14, n. 1, p. e1, doi. 10.1016/j.clml.2013.08.006
- By:
- Publication type:
- Article
Feasibility of Allografting in Patients with Advanced Acute Lymphoblastic Leukemia After Salvage Therapy With Inotuzumab Ozogamicin.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 3, p. 296, doi. 10.1016/j.clml.2012.12.003
- By:
- Publication type:
- Article